(Q39207806)

10 September 2017

Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface (English)

1 reference

10 September 2017

0 references

1

1 reference

10 September 2017

9

1 reference

10 September 2017

8

Christoffer Åberg

0 references

Kenneth A. Dawson

Kenneth A Dawson

10

0 references

Delyan R Hristov

Delyan R Hristov

6

0 references

Philip M Kelly

Philip M Kelly

7

0 references

Andrzej S Pitek

Andrzej S Pitek

Francesca Baldelli Bombelli

2

0 references

Francesca Baldelli Bombelli

5

0 references

Marco P Monopoli

Marco P Monopoli

3

0 references

Kanlaya Prapainop

4

Kanlaya Prapainop

1 reference

10 September 2017

language of work or name

English

0 references

publication date

20 January 2013

1 reference

10 September 2017

Nature Nanotechnology

1 reference

10 September 2017

8

1 reference

10 September 2017

2

1 reference

10 September 2017

137-143

1 reference

https://scigraph.springernature.com/pub.10.1038/nnano.2012.237

10 September 2017

0 references

cites work

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

1 reference

12 December 2020

Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

1 reference

12 December 2020

Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

1 reference

12 December 2020

Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group st

1 reference

12 December 2020

The role of transferrin in the mechanism of cellular iron uptake

1 reference

12 December 2020

Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging

1 reference

12 December 2020

Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation

1 reference

12 December 2020

Soft interactions at nanoparticles alter protein function and conformation in a size dependent manner

1 reference

12 December 2020

Bio-molecule-conjugated fluorescent organically modified silica nanoparticles as optical probes for cancer cell imaging

1 reference

12 December 2020

The transferrin receptor: a potential molecular imaging marker for human cancer

1 reference

12 December 2020

What the Cell “Sees” in Bionanoscience

1 reference

12 December 2020

Nanotechnology applications in cancer

1 reference

12 December 2020

Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population

1 reference

12 December 2020

Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics

1 reference

12 December 2020

Multifunctional nanoparticles possessing magnetic, long-lived fluorescence and bio-affinity properties for time-resolved fluorescence cell imaging

1 reference

12 December 2020

PEGylated nanoparticles for biological and pharmaceutical applications

1 reference

12 December 2020

Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor

1 reference

12 December 2020

Understanding biophysicochemical interactions at the nano-bio interface

1 reference

12 December 2020

Delivering nanomedicine to solid tumors

1 reference

12 December 2020

Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance

1 reference

12 December 2020

Frontiers in cancer nanomedicine: directing mass transport through biological barriers

1 reference

12 December 2020

Size and shape effects in the biodistribution of intravascularly injected particles.

1 reference

12 December 2020

Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptors

1 reference

12 December 2020

Targeting of drugs and nanoparticles to tumors

1 reference

12 December 2020

Cancer nanotechnology: opportunities and challenges

1 reference

12 December 2020

Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes

1 reference

12 December 2020

Physical approaches to biomaterial design

1 reference

12 December 2020

Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering

1 reference

12 December 2020

Strategies in the design of nanoparticles for therapeutic applications

1 reference

12 December 2020

Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery

1 reference

12 December 2020

Nanomedicine: current status and future prospects.

1 reference

12 December 2020

The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells

1 reference

12 December 2020

Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance

1 reference

12 December 2020

Identifiers

DOI

10.1038/NNANO.2012.237

1 reference

Dimensions Publication ID

10 September 2017

1048709708

0 references

Fatcat ID

release_lngtre2b4zcj3fs4mj73nf5nbe

0 references

1 reference